Mark Palangio

Dose Conversion and Titration with a Novel, Once-Daily, OROS® Osmotic Technology, Extended-Release Hydromorphone Formulation in the Treatment of Chronic Malignant or Nonmalignant Pain

Mark Palangio, Donald W. Northfelt, Russell K. Portenoy et al. · Journal of Pain and Symptom Management · 2002 · 81 citations · Full text

Medicine, Pharmaceutics, Pharmacology +14

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: A 9-year retrospective study at a single institution

Emil Bisaccia, Joselyn Gonzalez, Mark Palangio et al. · Journal of the American Academy of Dermatology · 2000 · 66 citations

Medicine, Dermatology, Oncology +8

Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain

Mark Palangio, E. W. T. Morris, Ralph T. Doyle et al. · Clinical Therapeutics · 2002 · 60 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Scleromyxedema with dermato-neuro syndrome

Joselyn Gonzalez, Mark Palangio, Joseph E. Schwartz et al. · Journal of the American Academy of Dermatology · 2000 · 44 citations · Full text

Medicine, Dermatology, Neurology +7

Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain

Mark Palangio, Michael Damask, Elena Morris et al. · Clinical Therapeutics · 2000 · 42 citations

Nursing, Pharmacology, Pharmacotherapy +16